best way to microdose glp 1 Microdosing GLP-1s: Safety, Dosage, Side Effects, and Results Thinking About Microdosing GLP-1? 5

doi: 10.1007/978-981-99-1463-0_1 213 SundararamanARayMRavindraPVHalamiPM

After 108 weeks, changes in UACR from baseline with lixisenatide were 1.69% [(95% CI: 11.69 to 8.30), p=0.7398] in patients with normoalbuminuria, 21.10% [(95% CI: 42.25 to 0.04), p=0.0502] in patients with microalbuminuria, and 39.18% [(95% CI: 6853 to 984), p=0.0070] in patients with macroalbuminuria

Some individuals prefer lower concentration formulations to reduce injection site discomfort, while others prefer higher concentrations to minimize injection volume

Caution should be used when Qsymia is prescribed with other drugs that predispose patients to heat-related disorders